Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 5/20 | 0.44 |
| ▸ | DDB1 | Q16531 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33927 | 0.87 | TDP1 (0.56) | TDP1ALDH1A1LMNACYP3A4THRB | |
| SCHEMBL1330911 | 0.87 | TDP1 (0.56) | TDP1ALDH1A1LMNACYP3A4THRB | |
| SCHEMBL1331551 | 0.87 | TDP1 (0.56) | TDP1ALDH1A1LMNACYP3A4THRB | |
| SCHEMBL1531678 | 0.87 | TDP1 (0.56) | TDP1ALDH1A1LMNACYP3A4THRB | |
| SCHEMBL33928 | 0.87 | TDP1 (0.56) | TDP1ALDH1A1LMNACYP3A4THRB | |
| Hydrochloric Acid SCHEMBL10445714 | 0.85 | TDP1 (0.54) | TDP1ALDH1A1LMNACYP3A4THRB | |
| Hydrochloric Acid SCHEMBL10424136 | 0.85 | TDP1 (0.54) | TDP1ALDH1A1LMNACYP3A4THRB | |
| SCHEMBL7468986 | 0.85 | TDP1 (0.54) | TDP1ALDH1A1LMNACYP3A4THRB | |
| Methane SCHEMBL6442579 | 0.85 | TDP1 (0.54) | TDP1ALDH1A1LMNACYP3A4THRB | |
| SCHEMBL7073966 | 0.85 | TDP1 (0.54) | TDP1ALDH1A1LMNACYP3A4THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3233796-B1 | POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS | DSM IP ASSETS BV (NL) | 2020-08-26 | — | — | EP | disclosed |
| EP-3233795-B1 | ALKYD RESIN COMPOSITIONS OF POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS | DSM IP ASSETS BV (NL) | 2020-05-13 | — | — | EP | disclosed |
| US-10189783-B2 | Polyfunctional compounds | DSM IP ASSETS B.V. (NL) | 2019-01-29 | — | — | US | disclosed |
| US-10066053-B2 | Alkyd resin compositions | DSM IP ASSETS B.V. (NL) | 2018-09-04 | — | — | US | disclosed |
| US-20170355672-A1 | POLYFUNCTIONAL COMPOUNDS | COVESTRO (NETHERLANDS) B.V. (NL) | 2017-12-14 | — | — | US | disclosed |
| US-20170327636-A1 | ALKYD RESIN COMPOSITIONS | COVESTRO (NETHERLANDS) B.V. (NL) | 2017-11-16 | — | — | US | disclosed |
| EP-3233795-A1 | ALKYD RESIN COMPOSITIONS OF POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS | DSM IP Assets B.V. (NL) | 2017-10-25 | — | — | EP | disclosed |
| EP-3233796-A1 | POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS | DSM IP Assets B.V. (NL) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016097403-A1 | POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2016-06-23 | — | — | WO | disclosed |
| WO-2016097404-A1 | ALKYD RESIN COMPOSITIONS OF POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170355672-A1 | POLYFUNCTIONAL COMPOUNDS | H1-3, H1-0, H1-2 | CRBN 267/4885DDB1 2186/4885TDP1 3270/4885 |
| US-10189783-B2 | Polyfunctional compounds | H1-3, H1-0, H1-2 | CRBN 267/4885DDB1 2186/4885TDP1 3270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.